Alamar Biosciences

MECHELEN, Belgium, August 10, 2026 Lakefront Biotherapeutics NV reported its half-year 2026 financial results and provided a business update...

FREMONT, California, August 10, 2026 Alamar Biosciences, Inc. announced an expansion of its strategic partnership with the Alzheimer’s Disease...

SEOUL, South Korea, July 27, 2026 Seegene Inc., a global leader in molecular diagnostics, has introduced a comprehensive syndromic...

FREMONT, Calif., July 28, 2026 Alamar Biosciences, Inc. has announced the commercial launch of the NULISAseq™ Immune 340 Panel,...

OSAKA, Japan; CAMBRIDGE, Massachusetts; JAKARTA, Indonesia — July 13, 2026 Takeda has entered into a landmark collaboration with the...

FREMONT, California, July 13, 2026 Alamar Biosciences has partnered with leading U.S. research universities to launch a national-scale proteomics...

CARLSBAD, California, July 13, 2026 ALZpath, Inc. has announced a major scientific milestone at the Alzheimer’s Association International Conference...

AMSTERDAM, Netherlands, June 2, 2026 Royal Philips has received U.S. FDA 510(k) clearance and CE Mark approval for Elevate...

FREMONT, California, USA, June 2, 2026 Alamar Biosciences has unveiled its NULISA™ Dried Blood Spot (DBS) Extraction Kit, a...

Fremont, California, March 17, 2026 Alamar Biosciences, Inc. announced the launch of its NULISAseq™ Neuro 220 Panel, a next-generation...